000 01419 a2200421 4500
005 20250516044728.0
264 0 _c20111209
008 201112s 0 0 eng d
022 _a1790-6245
040 _aNLM
_beng
_cNLM
100 1 _aWeidle, Ulrich H
245 0 0 _aSynthetic lethality-based targets for discovery of new cancer therapeutics.
_h[electronic resource]
260 _bCancer genomics & proteomics
_c
300 _a159-71 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBenzamides
650 0 4 _aDNA Repair
_xgenetics
650 0 4 _aDrug Design
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aGenes, Tumor Suppressor
650 0 4 _aGenes, myc
650 0 4 _aGenes, p53
650 0 4 _aGenes, ras
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
650 0 4 _aMutation
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aPoly(ADP-ribose) Polymerases
_xmetabolism
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProtein Kinases
_xdrug effects
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aRetinoblastoma Protein
_xgenetics
650 0 4 _aVon Hippel-Lindau Tumor Suppressor Protein
_xgenetics
700 1 _aMaisel, Daniela
700 1 _aEick, Dirk
773 0 _tCancer genomics & proteomics
_gvol. 8
_gno. 4
_gp. 159-71
999 _c20989852
_d20989852